The Indian government is keeping a hawk eye on medicines availability and pharma’s production readiness, including for the HIV combination lopinavir and ritonavir, as the country readies to tackle the threat of potential community transmission of the coronavirus infection.
As of 9.15am on 17 March, India had reported 125 confirmed COVID-19 disease cases, including foreign nationals, and two deaths...







